Pricing Log in Create free account
Friday 6 November 2026 Export BDX’s income statement to Excel — free account

Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

Becton, Dickinson and Company’s revenue for fiscal 2025 (year ended September 2025) was $21.8 billion, up 8.24% from fiscal 2024.

Revenue
−9.55%
EPS
−31.5%
Free cash flow
−31.6%
Total debt
−22.9%

Quarter to June 2026, against a year earlier

212.96 3.77 +1.80%
Market cap
$58.2B
P/E
64.1×
Fwd P/E
39.2×
Dividend yield
1.87%
F-score
7/9
Altman Z
1.85
Beneish M
−2.64
Dividend safety
67/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Becton, Dickinson and Company (BDX) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Becton, Dickinson and Company (BDX) trades at a EV/EBITDA of 14.9×. Over the past ten years it has ranged from 10.1× (January 2015) to 34.0× (June 2018); the current reading is higher than 31% of that period. That is in line with the Medical Instruments & Supplies industry median of 14.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 11.9× (22.17%)
FY2024 15.3× (7.06%)
FY2023 16.4× 16.71%
FY2022 14.1× (10.42%)
FY2021 15.7× (26.97%)
FY2020 21.5× 21.71%
FY2019 17.7× (13.35%)
FY2018 20.4× 39.64%
FY2017 14.6× (2.03%)
FY2016 14.9× (3.73%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 11.4× (4.46%)
Mar 2026 11.9× 1.81%
Dec 2025 11.7× (1.51%)
Sep 2025 11.9× (5.12%)
42 more quarters

Against its own ten years

Low 10.1× High 34.0×
Ten-year median 15.8×
Current reading's percentile 31

EV/EBITDA against peers

Company EV/EBITDA
MDLN Medline Inc. compare 4.5×
SOLV Solventum Corporation compare 7.6×
BAX Baxter International Inc. compare 13.2×
ALC Alcon compare 14.8×
BDX Becton, Dickinson and Company 14.9×
RMD ResMed Inc. compare 15.7×
COO The Cooper Companies, Inc. compare 15.8×
WST West Pharmaceutical Services, Inc. compare 28.4×
ISRG Intuitive Surgical, Inc. compare 38.3×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on BDX